Skip to content

THYMOLUX

Active Public limited companyfounded 2007active for 19 yearsMarloie, Rue du Point du Jour 8, 6900 Marche-en-FamenneKBO/BCE: BE 0889.156.042 #7 company by equity in Marche-en-Famenne, Manufacturing sector

Lifetime

18 annual accounts with figures on one time axis
peak of €6.4m in 2025
€6.4m▲ 70.5%
lowest -€754,837 in 2009
€1.6m▲ 31×
peak of €4.9m in 2025
€4.9m▲ 47.0%
€1.6m▼ 31.5%
peak of 32.6 FTE in 2021
23.9 FTE▼ 2.4%
Board14 names since 2013all names
5 directors and 4 others
Owners3 names in the annual accounts
25.04% and 1 other
Documentsfilings and deeds
06-07-202625 days before the deadline
2025abbreviated format
Turnover from €3.8m to €6.4mGross margin from €2.1m to €4.3mResult from €52,580 to €1.6m5 directors appointed 23-07Equity from €3.3m to €4.9mDebts from €2.3m to €1.6m

Key points

from the 2025 annual accounts

Equity

€4.9m ▲ 47.0%

THYMOLUX has made a profit without a break since 2010.

Result

€1.6m ▲ 31×
€52,6002024€1.6m2025

The result rose in 2025: different schema filed.

Staff

23.9 FTE from 32.6 in 2021

Between 2021 and 2025, 27% of the full-time equivalents disappeared.

Payment terms

142 days to suppliers
Suppliers
144 to 142
Customers
124 to 97

THYMOLUX pays its suppliers 2 days earlier than in 2024. Customers pay 27 days earlier.

Liquidity

2.83 was 1.34 in 2024

Short-term debts fell from €2.3m to €1.6m.

Position in the sector

€1.6m

Higher net result than 95% of companies in pharmaceuticals. Sector median -€4,260 · 84 companies.

Turnover +70%: other schema

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,811 companies had the same profile as THYMOLUX has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,760 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,811 companies, not a prediction for THYMOLUX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Chair
Director
Director,
Director
Director, since 30-06-2025
Auditor,
  • 25.04%score equity -€4,334 (2026) · 31-03-2026 annual accounts of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0889156042
5 directors appointed , (vice-chair), (chair), and · acts as permanent representative · General meeting of 30-06-2025 · Gazette deed
appointed as director resigns as director · General meeting of 26-06-2024 · Gazette deed
1 director appointed, 1 resignation resigns as managing director and chair · appointed · acts as permanent representative · General meeting of 14-06-2023 · Gazette deed
All 34 events

Comparable companies

same main activity, similar in size and age
Company
THYMOLUX Marche-en-Famenne €6.4m 32.3% 75.4% 23.9
KCI Polymedics Peer - - 90.8% 16.3
PHARMA CHEMICALS Braine-le-Château - - 32.0% 22.5
BIO MINERALS Destelbergen - - 67.2% 18.8
MEDI - LINE Liège €10.9m 4.4% 42.6% 56.6
BOIRON Evere €12.2m 4.2% 71.3% 59.7
Curium PET Liège Liège €2.8m -22.9% -145.4% 12.2
-10%0%10%20%€50,000€500,000€5m€50m€500m€5bnTHYMOLUXEBIT margin

Grey: the largest companies of the sector (pharmaceuticals (NACE 21)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as THYMOLUX: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209). They are comparable in size and age: total assets between €1.9m and €18m, founded between 1994 and 2017.

Official details

Source: KBO
Status
Active since 03-05-2007Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21209and 1 other
Joint committees
116Chemical industry
207White-collar workers in the chemical industry · annual accounts 2024
Establishment unit
2.172.026.8696900 Marche-en-Famenne, since 01-09-2008
Financial year end
31 December
Peppol
Reachable since 03-11-2025
Company details

Annual accounts 2025

€6.5m▲ 14.7%
Employeeson 31-12-2025
23▼ 8.0%
Filing
Filed on 06-07-2026, 25 days before the end of the filing period
Financials

Insights on THYMOLUX

THYMOLUX has existed since 2007. In 2010 turnover rose from €1.6m to €3.8m and staff from 10.1 to 30.1 full-time equivalents.

Solvency rose in 2025 from 58.8% to 75.4% because of the retained profit and lower debts.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about THYMOLUX

What is the company number of THYMOLUX?
The company number of THYMOLUX is 0889.156.042. The VAT number is the same number with BE in front: BE 0889.156.042.
Where is THYMOLUX based?
The registered office is at Marloie, Rue du Point du Jour 8, 6900 Marche-en-Famenne.Company details
What does THYMOLUX do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
What is the legal form of THYMOLUX?
THYMOLUX is a public limited company (NV).
When was THYMOLUX founded?
THYMOLUX was founded on 03-05-2007.
Is THYMOLUX still active?
Yes, THYMOLUX is an active enterprise in the KBO register.
How many employees does THYMOLUX have?
THYMOLUX had an average of 23.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does THYMOLUX fall under?
In its 2024 annual accounts, THYMOLUX states joint committees 116 (Chemical industry) and 207 (White-collar workers in the chemical industry).
What is the turnover of THYMOLUX?
The turnover of THYMOLUX was €6.4m in financial year 2025, according to the filed annual accounts.
Is THYMOLUX profitable?
In financial year 2025, THYMOLUX made a profit of €1.6m.
Where can I find the annual accounts of THYMOLUX?
THYMOLUX filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of THYMOLUX due?
THYMOLUX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.